Bain Capital Life Sciences Investors’s Aptinyx Inc. Common Stock APTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,891,758
| Closed | -$1.11M | – | 34 |
|
|
2023
Q1 | $1.11M | Hold |
8,891,758
| – | – | 0.14% | 33 |
|
|
2022
Q4 | $2.54M | Hold |
8,891,758
| – | – | 0.28% | 31 |
|
|
2022
Q3 | $3.27M | Hold |
8,891,758
| – | – | 0.39% | 31 |
|
|
2022
Q2 | $4.96M | Hold |
8,891,758
| – | – | 0.58% | 28 |
|
|
2022
Q1 | $20.2M | Hold |
8,891,758
| – | – | 1.96% | 13 |
|
|
2021
Q4 | $23.7M | Hold |
8,891,758
| – | – | 1.88% | 14 |
|
|
2021
Q3 | $20.8M | Hold |
8,891,758
| – | – | 1.29% | 18 |
|
|
2021
Q2 | $25.2M | Hold |
8,891,758
| – | – | 1.65% | 15 |
|
|
2021
Q1 | $26.7M | Hold |
8,891,758
| – | – | 1.51% | 14 |
|
|
2020
Q4 | $30.8M | Buy |
8,891,758
+3,333,333
| +60% | +$11.5M | 1.93% | 13 |
|
|
2020
Q3 | $18.8M | Hold |
5,558,425
| – | – | 1.75% | 14 |
|
|
2020
Q2 | $23.2M | Hold |
5,558,425
| – | – | 2.43% | 9 |
|
|
2020
Q1 | $12M | Buy |
5,558,425
+3,333,333
| +150% | +$7.2M | 2.03% | 10 |
|
|
2019
Q4 | $7.61M | Hold |
2,225,092
| – | – | 1.13% | 10 |
|
|
2019
Q3 | $7.77M | Hold |
2,225,092
| – | – | 2% | 7 |
|
|
2019
Q2 | $7.43M | Hold |
2,225,092
| – | – | 3.78% | 5 |
|
|
2019
Q1 | $9.01M | Hold |
2,225,092
| – | – | 3.6% | 6 |
|
|
2018
Q4 | $36.8M | Hold |
2,225,092
| – | – | 12.58% | 4 |
|
|
2018
Q3 | $64.4M | Hold |
2,225,092
| – | – | 14.62% | 3 |
|
|
2018
Q2 | $53.8M | Buy |
+2,225,092
| New | +$53.8M | 16.85% | 4 |
|